跳转至内容
Merck
CN

162558

4-氟-2-硝基苯胺

97%

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
FC6H3(NO2)NH2
化学文摘社编号:
分子量:
156.11
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
206-666-0
Beilstein/REAXYS Number:
2210197
MDL number:
Assay:
97%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

PUGDHSSOXPHLPT-UHFFFAOYSA-N

InChI

1S/C6H5FN2O2/c7-4-1-2-5(8)6(3-4)9(10)11/h1-3H,8H2

SMILES string

Nc1ccc(F)cc1[N+]([O-])=O

assay

97%

mp

90-94 °C (lit.)

functional group

fluoro, nitro

正在寻找类似产品? 访问 产品对比指南

Application

4-Fluoro-2-nitroaniline was used as starting reagent in the synthesis of 4-fluoro-N-ethyl-2-nitroaniline and N-(4-fluoro-2-nitrophenyl)-β-alanine.

General description

4-Fluoro-2-nitroaniline forms complexes with cobalt(II), nickel(II) and copper(II).

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

192.2 °F - closed cup

flash_point_c

89 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Complexes of copper (II), nickel (II) and cobalt (II) with 2-fluoro, 5-nitroaniline and 4-fluoro, 2-nitroaniline.
DeVoto G, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 38(7), 725-728 (1982)
Thomas Hussenether et al.
Bioorganic & medicinal chemistry, 12(10), 2625-2637 (2004-04-28)
Novel 4-arylpiperazin-1-yl-substituted 2,3-dihydro-1H-1,4- and 1H-1,5-benzodiazepines and their aza-analogues were synthesized as debenzoclozapine derivatives for evaluation as potential D4-ligands. While Ki values of some of the title compounds came within the range of clozapine, they showed an impressively greater selectivity over
S Singh et al.
The Journal of pharmacology and experimental therapeutics, 296(2), 600-611 (2001-02-13)
The diseases of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by mucus-congested airways. Agents that stimulate the secretion of Cl- are anticipated to facilitate mucociliary clearance and thus be of benefit in the treatment of CF

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持